Lonza Group AG has narrowed the list of bidders for its specialty ingredients unit, one of the European chemical industry’s most hotly-contested sale processes, people with knowledge of the matter said.
The Swiss company invited suitors including Carlyle Group Inc. and Bain Capital’s consortium with Cinven to make second-round offers, according to the people. Lone Star Funds and Partners Group Holding AG have also progressed to the next round of bidding for the Lonza business, the people said, asking not to be identified because the information is private.
Blackstone Group Inc., CVC Capital Partners and Clayton Dubilier & Rice are no longer in the running, the people said. The unit, which also attracted interest from Advent International and German chemicals group Lanxess AG, could fetch around 3.5 billion Swiss francs ($3.9 billion), Bloomberg News has reported.
The Lonza business manufactures chemicals for use in everything from paints to crop protection. Its microbial control solutions are also used in professional cleaning products and sanitizers, which have attracted strong demand amid the coronavirus pandemic.
Shares of Lonza have risen 54% in Zurich trading this year, giving the company a market value of about 40.6 billion francs. No final decisions have been made, and there’s no certainty the bidders will proceed with binding offers, the people said.
Representatives for Bain, Blackstone, Carlyle, CD&R, Cinven, CVC, Lone Star, Lonza and Partners declined to comment.
By Myriam Balezou, Dinesh Nair, and Jan-Henrik Foerster
Source: bloomberg.com
Syre, a joint venture between H&M and technology investment firm Vargas, announced plans to build a Gigascale recycling plant in Binh Dinh, which will produce up to 250,000 tonnes of high-quality polyethylene terephthalate (PET) chips from textile waste.
BASF SE (Ludwigshafen, Germany) has divested its shares in the joint venture (JV) companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd. Following approval by the relevant authorities, the transaction was completed effective April 21, 2025.
Lavie Bio is a recognized leader in the ag-biologicals industry with a robust pipeline of microbiome-based ag-biological products. Key assets to be transferred to ICL include Lavie Bio’s core team, the BDD technology platform, the company’s microbial bank and data assets, the majority of the company’s development programs, and its commercial products.
